{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:54:14Z","timestamp":1793242454568,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,15]]},"DOI":"10.1093\/cid\/cix043","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T13:27:11Z","timestamp":1485782831000},"page":"1074-1080","source":"Crossref","is-referenced-by-count":120,"title":["Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease"],"prefix":"10.1093","volume":"64","author":[{"given":"John A.","family":"Branda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemen","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise E.","family":"Nigrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Lantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin S.","family":"Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Steere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"key\n\t\t\t\t20170330052547_CIT0001","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170330052547_CIT0002","article-title":"Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease","volume":"75","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0004","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/CVI.00195-08","article-title":"Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease","volume":"15","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170330052547_CIT0005","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.00874-16","article-title":"Lyme borreliosis serology: performance of several commonly used laboratory diagnostic tests and a large resource panel of well-characterized patient samples","volume":"54","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170330052547_CIT0006","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/ciw427","article-title":"Evaluation of the C6 lyme enzyme immunoassay for the diagnosis of Lyme disease in children and adolescents","volume":"63","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0007","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/374395","article-title":"Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates","volume":"187","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0008","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cir464","article-title":"Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay","volume":"53","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for Lyme disease","volume":"47","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0010","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/JCM.01409-14","article-title":"Collection and characterization of samples for establishment of a serum repository for Lyme disease diagnostic test development and evaluation","volume":"52","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170330052547_CIT0011","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/CVI.00109-08","article-title":"Impact of clinical variables on Borrelia burgdorferi\u2013specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease","volume":"15","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170330052547_CIT0012","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432935","article-title":"Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0013","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","article-title":"The presenting manifestations of Lyme disease and the outcomes of treatment","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170330052547_CIT0014","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/vbz.2013.1365","article-title":"Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study","volume":"13","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0016","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1128\/JCM.01853-13","article-title":"Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of Lyme disease with noncutaneous manifestations","volume":"51","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170330052547_CIT0017","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","article-title":"High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice","volume":"18","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170330052547_CIT0018","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpeds.2016.04.004","article-title":"False positive Lyme disease IgM immunoblots in children","volume":"174","year":"2016","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170330052547_CIT0019","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1128\/IAI.69.12.7437-7444.2001","article-title":"Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease","volume":"69","year":"2001","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170330052547_CIT0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/648674","article-title":"2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/cit235","article-title":"Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0022","doi-asserted-by":"crossref","first-page":"21691","DOI":"10.1074\/jbc.M201547200","article-title":"Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi","volume":"277","year":"2002","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170330052547_CIT0023","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00075-07","article-title":"Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule","volume":"14","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170330052547_CIT0024","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/JCM.31.12.3090-3095.1993","article-title":"Serodiagnosis in early Lyme disease","volume":"31","year":"1993","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170330052547_CIT0025","first-page":"862","article-title":"Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients","volume":"142","year":"2006","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t20170330052547_CIT0026","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease","volume":"33","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0027","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/clind\/15.5.788","article-title":"Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease","volume":"15","year":"1992","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.diagmicrobio.2012.03.026","article-title":"Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease","volume":"73","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170330052547_CIT0029","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/art.30384","article-title":"Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or Lyme arthritis","volume":"63","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/8\/1074\/11120599\/cix043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T04:53:15Z","timestamp":1601527995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cix043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,1,27]]},"published-print":{"date-parts":[[2017,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix043","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}